Last quarter Janus International did something it had not done in this cycle: it admitted the year was not going to plan. Revenue and EBITDA guidance both came down, commercial demand fell off a cliff ...
Three months ago, Nine Energy Service offered investors two very different stories in one quarter. Its completion tools business posted a standout period, while its coil tubing operation lost an ...
Gilat Satellite Networks heads into its third-quarter report with a striking disconnect. Last quarter management sounded more confident than it had in a year, unveiling a deal to buy most of Comtech's ...
Hesai Group heads into its third-quarter report with an unusual disconnect. Management spent the last call recasting the company from a LiDAR supplier into a broader physical-AI platform, raising ...
Crescent Capital BDC heads into its September-quarter report with the market pricing it as though the turnaround has already failed. At $9.27, the shares trade at roughly half of the $17.82 net asset ...
Solmate Infrastructure Public Limited Company (formerly Brera Holdings PLC) (Nasdaq: SLMT) (“Solmate” or the “Company”), today announced that Alyazi Almheiri and Tarek Alnuaimi have resigned from the ...
Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard Time Upon closing, the combined company ...
Stockholders may obtain copies of the definitive Proxy Statement/Prospectus and other documents filed with the SEC, without charge, at the SEC's website at www.sec.gov or by directing a request to ...
Few biotech earnings reports hinge on a single number the way this one does. Wall Street expects Zymeworks to post roughly $249.7 million in third-quarter revenue when it reports after the close on ...
Tredegar Corporation (NYSE:TG) plans to release financial results for the third quarter of 2026 on November 6, 2026. About Tredegar Tredegar Corporation is an industrial manufacturer with two primary ...
Global Indemnity Group, LLC (NASDAQ: GBLI) (“GBLI” or the “Company”) plans an investor call in January to introduce Jessica Buss, its new Chief Executive Officer, who will set out her vision for GBLI ...
Coherus BioSciences heads into its third-quarter report with an odd disconnect. Three months ago, management delivered its most confident call in a year, finally putting a number on Loctorsi with full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results